Opportunity
Federal Register #2026-17685
NIAID Public Hearing on Proposed Organizational Reorganization
Buyer
National Institutes of Health
Posted
August 31, 2026
Respond By
September 18, 2026
Identifier
2026-17685
This notice announces a public hearing regarding a proposed reorganization within the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). - Purpose: Solicit public comments on the plan to abolish the Division of Clinical Research (DCR) and several offices, with clinical operations and oversight to be realigned across NIAID components - No procurement activity: The notice does not request products, services, or mention any OEMs or vendors - Focus: Organizational restructuring to align with Presidential priorities and NIAID's updated vision and mission - Oversight: Commitment to maintaining oversight and transparency in research activities - Audience: Stakeholders and the public are invited to provide input on the proposed changes
Description
The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) is accepting comments on a proposed reorganization involving the Division of Clinical Research (DCR). The reorganization aims to abolish several offices and the DCR, realigning clinical operations and oversight across multiple NIAID components. The goal is to better align with Presidential priorities and reflect the Institute's updated vision and mission focus while continuing important research with proper oversight and transparency. Comments are accepted from September 14th to September 18th, 2026.